ERBB2 and neoplasm: Cytotoxicity against Her2-positive SKOV3 cells will occur when the CD19-anti-Her2 bridging protein binds to both the anti-CD19 CAR domain on the CAR T cells and to the target tumor cells, thereby forming a cytotoxic synapse.